Skip to main content

Biopharmaceutical Manufacturing and Immunogenicity Study Guide

This guide explores the complex world of biopharmaceutical manufacturing, detailing the steps involved in producing therapeutic proteins, antibodies, vaccines, and cell therapies. It covers essential techniques like recombinant DNA technology, upstream and downstream processing, and antibody engineering. Furthermore, it delves into the critical aspects of immunogenicity, the mechanisms behind anti-drug antibody formation, and the challenges associated with emerging therapies. This resource is de

Save this study guide to your study set

Sign up free

Your learning path

Fundamentals of Immunology and Immune Responses

Immunology Overview and Immune System Mechanisms

A summary of the immune system including innate and adaptive immunity, antigen recognition, lymphocyte activation, and immune dysfunction.

  • Innate and adaptive immunity
  • Leukocyte lineages and functions
  • Antigen recognition and presentation pathways
  • MHC I and MHC II pathways
  • B-cell and T-cell activation
  • Humoral and cell-mediated immunity
  • Antibody effector functions
  • Immune tolerance and autoimmunity
  • Hypersensitivity types
  • Anti-tumour response and immune evasion

Biopharmaceuticals, Monoclonal Antibodies, and Oligonucleotide Therapeutics

Nucleic Acid Therapeutics and Vaccine Mechanisms

Nucleic acids including DNA and RNA serve as templates for oligonucleotide therapeutics, mRNA vaccines, and various mechanisms of gene expression modulation.

  • Nucleic acid structure
  • Central Dogma
  • Oligonucleotide therapeutics
  • Antisense oligonucleotides (ASO)
  • Aptamers
  • mRNA therapeutics
  • Lipid nanoparticles
  • mRNA vaccine mechanisms
  • Innate and adaptive immunity
  • RNA splicing
  • RNase H-mediated cleavage
  • Steric hindrance
  • Splice modulation
  • Vaccine types

Biopharmaceutical Manufacturing and Immunogenicity

Biopharmaceutical Manufacturing and Immunogenicity

Processes for manufacturing recombinant proteins, monoclonal antibodies, insulin, vaccines, oligonucleotides, and cell therapies including upstream and downstream processing and the mechanisms of anti-drug antibody formation.

  • Recombinant DNA technology
  • Upstream processing
  • Downstream processing
  • Hybridoma technology
  • Monoclonal antibody humanisation
  • Chimeric monoclonal antibodies
  • Industrial insulin production
  • Bioreactor scale-up
  • Biosimilar manufacturing
  • Immunogenicity
  • Neutralising anti-drug antibodies
  • Non-neutralising anti-drug antibodies
  • T-cell-dependent pathway
  • T-cell-independent pathway
  • CAR-T cell therapy manufacturing
  • Oligonucleotide solid-phase synthesis
  • Egg-based influenza vaccine manufacturing

Make it your own.

Keep these readings and topics in a new study set, or add them to one you already use.

Get started freeLog in